Jafron Biomedical Co.,Ltd. (300529.SZ)
- Previous Close
23.30 - Open
22.40 - Bid 26.14 x --
- Ask 26.15 x --
- Day's Range
24.06 - 26.47 - 52 Week Range
15.88 - 29.67 - Volume
32,811,619 - Avg. Volume
6,770,378 - Market Cap (intraday)
21.118B - Beta (5Y Monthly) --
- PE Ratio (TTM)
47.55 - EPS (TTM)
0.55 - Earnings Date --
- Forward Dividend & Yield 0.67 (2.56%)
- Ex-Dividend Date May 31, 2023
- 1y Target Est
26.62
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sales of blood purification products for hemadsorption industry in China and internationally. The company offers solutions for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, kidney, and liver diseases; HA series hemoperfusion cartridge, BS bilirubin adsorption column and DNA immunoadsorption column, hemoperfusion machine, and blood purification machine; and other products, such as hemodialyzer, hemodialysis concentrate, disinfectants, resin bandages, online hemodialysis powder bag/bucket, and adsorbable suture with needles. The company was founded in 1989 and is based in Zhuhai, China.
www.jafroninternational.comRelated News
Performance Overview: 300529.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300529.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300529.SZ
Valuation Measures
Market Cap
21.12B
Enterprise Value
20.15B
Trailing P/E
47.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.69
Price/Book (mrq)
6.79
Enterprise Value/Revenue
10.33
Enterprise Value/EBITDA
35.91
Financial Highlights
Profitability and Income Statement
Profit Margin
25.06%
Return on Assets (ttm)
6.82%
Return on Equity (ttm)
14.65%
Revenue (ttm)
2.09B
Net Income Avi to Common (ttm)
524.73M
Diluted EPS (ttm)
0.55
Balance Sheet and Cash Flow
Total Cash (mrq)
3.14B
Total Debt/Equity (mrq)
55.79%
Levered Free Cash Flow (ttm)
735.4M
Research Analysis: 300529.SZ
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 300529.SZ
300529.SZ does not have Company Insights